A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 104 participants.
Also called NCT07318155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 104 participants
- Sponsor
- Sirius Therapeutics Co., Ltd.
- Registry
-
NCT07318155
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07318155. Randomized; quadruple masking; primary purpose treatment. Start 2025-03-11 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
- Condition
- Peripheral Arterial Disease
- Intervention (Drug)
- SRSD107
- Intervention (Drug)
- 0.9 % sodium chloride
- Lead sponsor
- Sirius Therapeutics Co., Ltd.
Record details
- Record id
cardio:ct-nct07318155- Content hash
3f1db91a64842f56c5a4c09347f769520d61d5b2aa8ced0d65e3cb5f54c7acb9